BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 21480865)

  • 1. Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways.
    Gomez O; Sanchez-Rodriguez A; Le M; Sanchez-Caro C; Molina-Holgado F; Molina-Holgado E
    Br J Pharmacol; 2011 Aug; 163(7):1520-32. PubMed ID: 21480865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Basal Tone of 2-Arachidonoylglycerol Contributes to Early Oligodendrocyte Progenitor Proliferation by Activating Phosphatidylinositol 3-Kinase (PI3K)/AKT and the Mammalian Target of Rapamycin (MTOR) Pathways.
    Gomez O; Sanchez-Rodriguez MA; Ortega-Gutierrez S; Vazquez-Villa H; Guaza C; Molina-Holgado F; Molina-Holgado E
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):309-17. PubMed ID: 25900077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling.
    Molina-Holgado E; Vela JM; Arévalo-Martín A; Almazán G; Molina-Holgado F; Borrell J; Guaza C
    J Neurosci; 2002 Nov; 22(22):9742-53. PubMed ID: 12427829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction.
    Sánchez MG; Ruiz-Llorente L; Sánchez AM; Díaz-Laviada I
    Cell Signal; 2003 Sep; 15(9):851-9. PubMed ID: 12834810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling.
    Palazuelos J; Ortega Z; Díaz-Alonso J; Guzmán M; Galve-Roperh I
    J Biol Chem; 2012 Jan; 287(2):1198-209. PubMed ID: 22102284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CB2 cannabinoid receptors promote mouse neural stem cell proliferation.
    Molina-Holgado F; Rubio-Araiz A; García-Ovejero D; Williams RJ; Moore JD; Arévalo-Martín A; Gómez-Torres O; Molina-Holgado E
    Eur J Neurosci; 2007 Feb; 25(3):629-34. PubMed ID: 17328768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
    McCollum L; Howlett AC; Mukhopadhyay S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes.
    Mato S; Alberdi E; Ledent C; Watanabe M; Matute C
    Glia; 2009 Feb; 57(3):295-306. PubMed ID: 18814177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling.
    Molina-Holgado F; Pinteaux E; Heenan L; Moore JD; Rothwell NJ; Gibson RM
    Mol Cell Neurosci; 2005 Jan; 28(1):189-94. PubMed ID: 15607953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type-1 (CB1) cannabinoid receptor promotes neuronal differentiation and maturation of neural stem cells.
    Compagnucci C; Di Siena S; Bustamante MB; Di Giacomo D; Di Tommaso M; Maccarrone M; Grimaldi P; Sette C
    PLoS One; 2013; 8(1):e54271. PubMed ID: 23372698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation.
    Gomez O; Arevalo-Martin A; Garcia-Ovejero D; Ortega-Gutierrez S; Cisneros JA; Almazan G; Sánchez-Rodriguez MA; Molina-Holgado F; Molina-Holgado E
    Glia; 2010 Dec; 58(16):1913-27. PubMed ID: 20878765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
    Kokona D; Thermos K
    Exp Eye Res; 2015 Jul; 136():45-58. PubMed ID: 25989217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms for the coupling of cannabinoid receptors to intracellular calcium mobilization in rat insulinoma beta-cells.
    De Petrocellis L; Marini P; Matias I; Moriello AS; Starowicz K; Cristino L; Nigam S; Di Marzo V
    Exp Cell Res; 2007 Aug; 313(14):2993-3004. PubMed ID: 17585904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors.
    Scutt A; Williamson EM
    Calcif Tissue Int; 2007 Jan; 80(1):50-9. PubMed ID: 17205329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Chronic Alcohol Exposure on the Modulation of Ischemia-Induced Glutamate Release via Cannabinoid Receptors in the Dorsal Hippocampus.
    Zheng L; Wu X; Dong X; Ding X; Song C
    Alcohol Clin Exp Res; 2015 Oct; 39(10):1908-16. PubMed ID: 26343919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligodendrocyte differentiation and signaling after transferrin internalization: a mechanism of action.
    Pérez MJ; Fernandez N; Pasquini JM
    Exp Neurol; 2013 Oct; 248():262-74. PubMed ID: 23797152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
    Calik MW; Carley DW
    Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling.
    Börner C; Smida M; Höllt V; Schraven B; Kraus J
    J Biol Chem; 2009 Dec; 284(51):35450-60. PubMed ID: 19858202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
    Mulè F; Amato A; Baldassano S; Serio R
    Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.
    Luca T; Di Benedetto G; Scuderi MR; Palumbo M; Clementi S; Bernardini R; Cantarella G
    Eur J Pharmacol; 2009 Aug; 616(1-3):16-21. PubMed ID: 19539619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.